zantac Archives - Borgess Law

ZANTAC CANCER LITIGATION UPDATE- Proceedings to Be Held Via Video Conference

May 7, 2020

HEARTBURN MEDICATION RECALLS DUE TO CANCER RISK: LITIGATION UPDATE

For individuals who developed cancer after taking Zantac or other ranitidine medication, multiple Zantac lawsuits have now been filed across the country accusing drug makers of manufacturing, marketing and selling a product they knew or should have known had a chemical known to cause cancer, yet did nothing to warn consumers. In February, 2020, the...

FDA Requests Immediate Withdraw of Zantac & Other Ranitidine Products from the Market

April 2, 2020

What you should know: On April 1, 2020, the FDA requested that all manufacturers immediately withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market. The generic name for the drug Zantac is ranitidine. The medication may contain a cancer-causing chemical. Some ranitidine medications had already been recalled prior to this announcement. Lawsuits have been...

Tag: zantac

ZANTAC CANCER LITIGATION UPDATE- Proceedings to Be Held Via Video Conference

FDA Requests Immediate Withdraw of Zantac & Other Ranitidine Products from the Market